A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus Dose

Trial Profile

A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus Dose

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2017

At a glance

  • Drugs Cyclopropyl-methoxycarbonylmetomidate (Primary)
  • Indications Anaesthesia
  • Focus Adverse reactions; First in man; Pharmacodynamics
  • Sponsors Annovation BioPharma
  • Most Recent Events

    • 01 Jul 2017 Results published in the Anesthesiology
    • 17 Feb 2016 According to The Medicines Company media release, the company presented the first clinical results addressing the safety and tolerability of ABP-700 at the ANESTHESIOLOGY 2015 and International Society of Anesthetic Pharmacologists annual meetings.
    • 26 Oct 2015 Results from this trial were presented at the annual meetings of ANESTHESIOLOGY 2015 and The International Society of Anesthetic Pharmacologists, according to The Medicines Company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top